139 related articles for article (PubMed ID: 9930867)
1. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection.
Dittmer U; Brooks DM; Hasenkrug KJ
Nat Med; 1999 Feb; 5(2):189-93. PubMed ID: 9930867
[TBL] [Abstract][Full Text] [Related]
2. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
3. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
4. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
5. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
[TBL] [Abstract][Full Text] [Related]
9. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
10. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
11. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
12. Protection against establishment of retroviral persistence by vaccination with a live attenuated virus.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1999 May; 73(5):3753-7. PubMed ID: 10196269
[TBL] [Abstract][Full Text] [Related]
13. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine against Friend erythroleukaemia virus.
Síma P; Smahel M; Jelínek F; Vonka V
Folia Biol (Praha); 2002; 48(2):43-50. PubMed ID: 12002674
[TBL] [Abstract][Full Text] [Related]
18. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
19. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
[TBL] [Abstract][Full Text] [Related]
20. Envelope exchange for the generation of live-attenuated arenavirus vaccines.
Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD
PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]